First-in-human study of [18F]DiFA - First-in-human study of [18F]DiFA

Hokkaido University Hospital0 个研究点目标入组 8 人开始时间: 2016年5月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) The person who is abnormal in laboratory study at screening. White blood cell differentiation is excluded) (2)a history of blood, heart, hepatic or renal disease. (3)The person who had an acute disease symptom (nausea, vomiting, fever, diarrhea) within 3 days before screening test (4)any medical treatment including vitamin drug and Kanpo-drug within 7 days before enrollment. (5)a donation of plasma to a blood bank or clinical study within 7 days before enrollment. a donation of over 200 ml whole blood to a blood bank or clinical studywithin 28 days before enrollment. a donation of over 400 ml whole blood to a blood bank or clinical study within 84 days before enrollment. a donation of over 800 ml whole blood to a blood bank or clinical study within 365 days before enrollment. (6) a history of hypersensitivity for medical drugs. (7)a participation in other clinical trials at present or other clinical trial within 6 months before enrollment. (8) a history of drug abuse or alcoholism. (9)The person of the severe claustrophobia. (10) The person who has a history of the poor physical condition by the medical act including drawing blood, the injection (11)and subjects were excluded if the investigators judged as misfit for this study.

发起方